Vistagen Therapeutics, Inc. (VTGN): Form 8-K filed 2026-10-30
- Accepted by EDGAR
- 2026-10-30 17:24 ET
- Event date
- 2026-10-26
- Accession no.
- 0001628280-26-068627
- Original filing
- SEC EDGAR filing index
Items reported
- Item 2.05: Cost Associated with Exit or Disposal Activities
The company committed to an exit or disposal plan, such as a restructuring, facility closure or workforce reduction, under which it expects to incur material charges. - Item 8.01: Other Events
A voluntary disclosure of an event the company considers important to security holders that no other Item covers, such as a dividend declaration, a buyback program, litigation updates or product news.
Documents
| Type | Description | Document |
|---|---|---|
| 8-K | 8-K | vtgn-20261026.htm |
This page lists what the filing reports; it does not summarize or interpret it. Read the original documents on SEC EDGAR. How to read an 8-K.